Juan Carlos Tercero

Juan Carlos is head of product development at Inbiomotion. He was previously head of molecular medicine of PharmaMar (Zeltia Group) for eight years, where he was responsible for pharmacogenomics and translational research projects. These projects focused on the elucidation of mechanism of action and the identification of biomarkers of drug response for the clinical development of anti-cancer compounds.

Previously he was director of the Pharmacogenomics Laboratory and technical director of PharmaGen (Madrid, Spain), a company providing DNA fingerprinting services and developing molecular diagnostic kits for detection of tumor markers and infectious diseases using PCR techniques. Before that, he spent three years in post-doctoral training in biomedical research at the National Institutes of Health (USA).

Juan Carlos holds a PhD in biology from the U. Complutense de Madrid.